Related Experiment Video
Updated: Feb 25, 2026

Time-resolved ElectroSpray Ionization Hydrogen-deuterium Exchange Mass Spectrometry for Studying Protein Structure and Dynamics
Published on: April 17, 2017
KRAS G12C Drug Development: Discrimination between Switch II Pocket Configurations Using Hydrogen/Deuterium-Exchange
Jia Lu1, Rane A Harrison2, Lianbo Li1
1Departments of Biochemistry and Radiation Oncology, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA.
Abstract:
KRAS G12C, the most common RAS mutation found in non-small-cell lung cancer, has been the subject of multiple recent covalent small-molecule inhibitor campaigns including efforts directed at the guanine nucleotide pocket and separate work focused on an inducible pocket adjacent to the switch motifs. Multiple conformations of switch II have been observed, suggesting that switch II pocket (SIIP) binders may be capable of engaging a range of KRAS conformations. Here we report the use of hydrogen/deuterium-exchange mass spectrometry (HDX MS) to discriminate between conformations of switch II induced by two chemical classes of SIIP binders. We investigated the structural basis for differences in HDX MS using X-ray crystallography and discovered a new SIIP configuration in response to binding of a quinazoline chemotype. These results have implications for structure-guided drug design targeting the RAS SIIP.
Insights
Researchers used HDX-MS to study KRAS G12C conformations targeted by SIIP binders. A new SIIP configuration was found with a quinazoline inhibitor, aiding structure-guided drug design for non-small-cell lung cancer.
Area of Science:
- Oncology
- Structural Biology
- Biochemistry
Background:
- KRAS G12C is a common mutation in non-small-cell lung cancer (NSCLC).
- Targeting KRAS involves inhibiting its guanine nucleotide pocket or an inducible pocket (SIIP) near switch motifs.
- SIIP binders may interact with diverse KRAS conformations due to switch II flexibility.
Purpose of the Study:
- To differentiate KRAS switch II conformations induced by distinct SIIP binder chemical classes.
- To elucidate the structural basis for observed HDX-MS differences.
- To identify novel SIIP configurations relevant for drug design.
Main Methods:
- Hydrogen/deuterium-exchange mass spectrometry (HDX MS) to analyze protein backbone dynamics.
- X-ray crystallography to determine high-resolution protein structures.
- Utilizing two chemical classes of SIIP binders to probe KRAS conformations.
Main Results:
- HDX MS successfully discriminated between KRAS switch II conformations induced by different SIIP binders.
- X-ray crystallography revealed the structural basis for HDX MS findings.
- A novel SIIP configuration was identified upon binding of a quinazoline-based inhibitor.
Conclusions:
- HDX MS is effective for characterizing KRAS conformational states induced by SIIP binders.
- The discovery of a new SIIP configuration offers insights for structure-guided drug design.
- These findings advance the development of targeted therapies for KRAS-mutated NSCLC.
Related Concept Videos
High-Resolution Mass Spectrometry (HRMS)
¹³C NMR: Distortionless Enhancement by Polarization Transfer (DEPT)
2D NMR: Heteronuclear Single-Quantum Correlation Spectroscopy (HSQC)
¹H NMR of Labile Protons: Deuterium (²H) Substitution
¹³C NMR: ¹H–¹³C Decoupling
A broadband decoupling technique is used to simplify these complex, sometimes overlapping, signals. Broadband decoupling relies on a...
Tandem Mass Spectrometry

